OR WAIT null SECS
May 10, 2019
EMA has launched a social media campaign aimed at highlighting how the agency and its network maintain safety and efficacy of medicines available in Europe.
May 02, 2019
In Karl Fischer analysis, sulfur trioxide can react with DMSO, invalidating test results. The authors evaluated different instruments and methods, described in this article, to minimize the impact on results.
May 01, 2019
The UK’s General Pharmaceutical Council (GPhC) has strengthened its guidance for online pharmacies to further safeguard patients when purchasing medicines.
The CHMP has recommended that Sixmo (buprenorphine) be granted a marketing authorization in the EU as a substitution treatment for opioid dependence.
EMA has revealed that it is updating the prescribing information of Tyverb (lapatinib) as a result of the detection of errors in study results.
Delays in revisions to guidelines by the European Union are impeding the pharmaceutical industry.
Horizon Europe gains parliamentary endorsement, bringing it closer to becoming a reality.
A new conference is set to provide a platform for European regulatory professionals to come together to discuss relevant issues and share expertise.
April 30, 2019
The company’s center of excellence for advanced analytical testing passed GMP inspection from the European Medicines Agency.
April 26, 2019
The Regulatory Affairs Professional Society (RAPS) has released an updated agenda for its forthcoming conference, RAPS Regulatory Conference-Europe 2019.